 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval9 b `& B) t9 ]6 q, x/ p% }7 p' _, [
& a# o* Y( y" k+ IEDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.! L: Z& f" Q. z* S; f
; z3 G/ B: c# v( pBY THE EDMONTON JOURNAL FEBRUARY 16, 2007
5 {$ ?" K, N7 {0 P; G+ y ) Q6 e9 ~0 W7 Z4 f3 F
5 F+ U- x; d" j# QEDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.( N' G- C5 x& i1 y- W1 q8 n
1 n$ S+ v, q" X2 x( X1 ^0 j
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."$ c/ {* x X2 _0 f3 R+ R
$ P5 q5 f1 L- H
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
H8 N# Y6 [& Z" p5 P% @& b0 e: m1 v5 E: }3 [ i( `
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday. G4 s. g6 X+ q. ~7 [7 j$ _" b( f8 v
2 h4 W/ [/ h+ s! i# k+ h$ W4 z
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
9 A( W( M( `1 x9 Z0 k
, L& m& z4 n+ }) _# ~6 N"As a scientist, it's one of the highlights of my CAREER," Shan said.
8 s! d4 O; ]3 S# g; `; U) X6 ?) m5 a5 K
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
7 V; M9 l, B: W6 V |4 k% U# D$ z9 C* K! d: t, v9 J/ j V
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
0 N3 D( {3 q0 I. _5 y1 n2 q% |3 Z! y" W1 q( M* Z1 w
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.1 `3 w8 F. T3 O2 R0 E& d/ a
6 s q: H- U2 s2 @1 SThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
5 v! ^0 r. c+ [3 [
6 J/ M1 x0 j( L9 X4 a; Z' x. `9 G( N
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
* ] T/ \# Q+ b( u8 H0 e
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
发表于 2015-2-28 19:45
